Flumedrokson
|
|
Klinički podaci
|
AHFS/Drugs.com
|
Monografija
|
Identifikatori
|
CAS broj
|
987-18-8
|
ATC kod
|
N02CB01
|
PubChem[1][2]
|
71881
|
UNII
|
K80185F39X Y
|
Hemijski podaci
|
Formula
|
C22H29F3O3
|
Mol. masa
|
398,459
|
SMILES
|
eMolekuli & PubHem
|
InChI |
InChI=1S/C22H29F3O3/c1-12(26)21(28)9-6-16-14-11-18(22(23,24)25)17-10-13(27)4-7-19(17,2)15(14)5-8-20(16,21)3/h10,14-16,18,28H,4-9,11H2,1-3H3/t14?,15?,16?,18-,19+,20-,21+/m0/s1 Key: CDZJOBWKHSYNMO-BQVNIZPZSA-N Y |
|
Sinonimi
|
(6S,10R,13S,17S)-17-acetyl-17-hydroxy-10,13-dimethyl-6-(trifluoromethyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one 17-Acetyloxy-6α-(trifluoromethyl)preg-4-ene-3,20-dione
|
Farmakoinformacioni podaci
|
Trudnoća
|
?
|
Pravni status
|
|
Flumedrokson je organsko jedinjenje, koje sadrži 22 atoma ugljenika i ima molekulsku masu od 398,459 Da.
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o.
- ↑ Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.
- ↑ Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.